瑞科生物-B

02179
3.9000.00% ( 0.000 )
延遲 已收盤: 11月20日 16:08:00

股東

全部股東

股東類型

  • 私人企業31.60%
  • 公眾及其他17.06%
  • 機構投資者16.66%
  • 僱員持股計劃13.74%
  • 其他20.94%

主要股東

主要股東 最新
股東
Yangtze River Pharmaceutical Group Co. Ltd
23.20%1.43 億0.00%+029/04/2026
Taizhou Yuangong Technology Partnership (Limited Partnership)
13.43%8,286.36 萬0.00%+029/04/2026
Lhasa Junqi Enterprise Management Co., Ltd.
6.79%4,186.10 萬0.00%+031/12/2025
Taizhou Chaorui Medical Technology Partnership (Limited Partnership)
6.06%3,739.00 萬0.00%+029/04/2026
Hongyan Liu
5.68%3,503.79 萬0.00%+031/12/2025
Lyfe Capital
5.59%3,449.98 萬2.94%+1,815.17 萬30/04/2026
Shenzhen Qianhai Woying Investment Management Co., Ltd
4.41%2,720.37 萬0.00%+031/12/2025
Jiangsu Zhaoyin Industry Fund Management Co., Ltd.
4.11%2,536.92 萬0.00%+029/04/2026
Shenzhen Oriental Fortune Venture Capital Management Co., Ltd.
2.64%1,630.09 萬0.00%+029/04/2026
Shenzhen Fuhai Xinwan Equity Investment Fund Management Enterprise (L.P.)
2.56%1,577.06 萬0.00%+029/04/2026
Yangtze River (Hong Kong) Limited
2.05%1,261.85 萬0.00%+029/04/2026
Yong LiuFounder, Executive Director & GM
1.99%1,229.42 萬0.00%+029/04/2026
Sequoia Capital Operations LLC
1.45%896.25 萬0.00%+015/12/2025
Legend Capital Management Co., Ltd.
0.96%592.14 萬0.00%+031/12/2025
Haoyu XuNon-Executive Chairman
0.64%395.75 萬0.00%+029/04/2026
Shenzhen Oriental Fortune Capital Co., Ltd.
0.31%191.44 萬0.00%+029/04/2026
Taizhou Baibei Biology Technology Partnership (Limited Partnership)
0.25%152.50 萬0.00%+029/04/2026
Shenzhen Qianhai Kekong Hong Kong-Shenzhen Venture Capital Co., Ltd.
0.21%132.17 萬0.00%+029/04/2026
Jiayi Zhao
0.21%128.15 萬0.00%+031/12/2025
Taizhou Xinchuan Law Firm (Limited Partnership)
0.17%106.91 萬0.00%+029/04/2026